351. Deputy Margaret Murphy O'Mahony asked the Minister for Health if the clinical trial of the drug Respreeza, which treats emphysema caused by severe alpha-1, will continue to be made available to the 21 patients who are currently receiving the drug; if it will be made available to approximately 40 more patients if current assessments are favourable; and if he will make a statement on the matter. [33553/16]

Summary

351. Deputy Margaret Murphy O'Mahony asked the Minister for Health if the clinical trial of the drug Respreeza, which treats emphysema caused by severe alpha-1, will continue to be made available to the 21 patients who are currently receiving the drug; if it will be made available to approximately 40 more patients if current assessments are favourable; and if he will make a statement on the matter. [33553/16]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 8 November 2016

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.